| 1. |
Meinnel T, Peynot P, Giglione C. Processed N-termini of mature proteins in higher eukaryotes and their major contribution to dynamic proteomics. Biochimie, 2005, 87(8): 701-712.
|
| 2. |
Silva RD, Martinho RG. Developmental roles of protein N-terminal acetylation. Proteomics, 2015, 15(14): 2402-2409.
|
| 3. |
D?rfel MJ, Lyon GJ. The biological functions of Naa10—From aminoterminal acetylation to human disease. Gene, 2015, 567(2): 103-131.
|
| 4. |
Park JH, Seo JH, Wee HJ, et al. Nuclear translocation of hARD1 contributes to proper cell cycle progression. PloS One, 2014, 9(8): e105185.
|
| 5. |
Chang YY, Hsu CH. Structural basis for substrate-specific acetylation of Nα-acetyltransferase Ard1 from Sulfolobus solfataricus. Sci Rep, 2015, 5: 8673.
|
| 6. |
Kuo HP, Lee DF, Chen CT, et al. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal, 2010, 3(108): ra9.
|
| 7. |
Ma C, Pathak C, Jiang S, et al. Structure of Thermoplasma volcanium Ard1 belongs to N-acetyltransferase family member suggesting multiple ligand binding modes with acetyl coenzyme A and coenzyme A. Biochim Biophys Acta, 2014, 1844(10): 1790-1797.
|
| 8. |
Gioeli D, Paschal BM. Post-translational modification of the androgen receptor. Mol Cell Endocrinol. 2012, 352(1-2): 70-78.
|
| 9. |
Hanahan D, Weinberg RA. Hallmarks of cancer:the next generation. Cell, 2011, 144(5): 646-674.
|
| 10. |
Zeng Y, Min L, Han Y, et al. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis. Carcinogenesis, 2014, 35(10): 2244-2253.
|
| 11. |
白松, 周媛媛, 田風, 等. ARD1在人大腸腺癌細胞SW620、LS-174T和HCT-8中的表達.南方醫科大學學報, 2011, 31(5): 914-916.
|
| 12. |
Wang ZH, Wang ZM, Guo JH, et al. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Proc Natl Acad Sci U S A, 2012, 109(8): 3053-3058.
|
| 13. |
Arnesen T, Kong X, Evjenth R, et al. Interaction between HIF-1α(ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α. FEBS Lett, 2005, 579(28): 6428-6432.
|
| 14. |
Ren T, Jiang B, Jin G, et al. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer let, 2008, 264(1): 83-92.
|
| 15. |
Crabtree MD, Fletcher C, Churchman M, et al. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut, 2004, 53(2): 271-276.
|
| 16. |
Xu HY, Jiang B, Meng L, et al. N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression. Carcinogenesis, 2012, 33(6): 1193-1202.
|
| 17. |
余敏, 黃超, 向明鈞, 等.抗hARD1抗血清制備及其初步腫瘤免疫組化分析.生物工程學報, 2008, 52(7): 1155-1161.
|
| 18. |
Shin SH, Yoon H, Chun YS, et al. Arrest defective 1 regulates the oxidative stress response in human cells and mice by acetylating methionine sulfoxide reductase A. Cell Death Dis, 2014, 5: e1490.
|
| 19. |
?nal M, Y?lmaz T, Bilgi? E, et al. Possible role of apoptosis in pathogenesis of adenoid hypertrophy and chronic adenoiditis: Prospective case-control study. Auris Nasus Larynx, 2015, 42 (6): 449-452.
|
| 20. |
Xu HL, Yu XF, Qu SC, et al. Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway. Eur J Pharmacol, 2010, 645(1-3): 14-22.
|
| 21. |
Min L, Xu H, Wang J, et al. N-α-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β. FEBS Lett, 2013, 587(11): 1630-1637.
|
| 22. |
Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev, 1992, 11(2): 121-139.
|
| 23. |
Park J, Kanayama A, Yamamoto K, et al. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. Biochem Biophys Res Commun, 2012, 422(2): 291-297.
|
| 24. |
Fisher TS, Etages SD, Hayes L, et al. Analysis of h ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem, 2005, 280(18): 17749-17757.
|
| 25. |
Perez RE, Knights CD, Sahu G, et al. Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway. J Cell Physiol, 2010, 225(2): 394-405.
|
| 26. |
Rocha G, Villalobos E, Fuentes C, et al. Preadipocyte proliferation is elevated by calcium sensing receptor activation. Mol Cell Endocrinol, 2015, 412: 251-256.
|
| 27. |
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science, 1994, 266(5192): 1821-1828.
|
| 28. |
Foyn H, Jones JE, Lewallen D, et al. Design, synthesis, and kinetic characterization of protein N-terminal acetyltransferase inhibitors. ACS Chem Biol, 2013, 8(6): 1121-1127.
|
| 29. |
Seo JH, Park JH, Lee EJ, et al. Different subcellular localizations and functions of human ARD1 variants. Int J Oncol, 2015, 46(2): 701-707.
|
| 30. |
Seo JH, Park JH, Lee EJ, et al. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis. Int J Oncol, 2015, 46(1): 99-106.
|
| 31. |
Liu C, Qu L, Dong B, et al. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer. Am J Med Sci, 2012, 343(4): 295-302.
|
| 32. |
Yamada HY, Rao CV. BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy. Int J Oncol, 2009, 35(5): 1101-1109.
|
| 33. |
白松, 邵佳發, 王維琦, 等. hARD1在人大腸腺癌中的表達及與腫瘤分化的相關性.世界華人消化雜志, 2011, 19(15): 1585-1590.
|
| 34. |
Steffens CC, Tschechne B, Schardt C, et al. Observational study of adjuvant therapy with capecitabine in colon cancer. Curr Med Res Opin, 2015, 31(4): 731-741.
|
| 35. |
Wang ZH, Gong JL, Yu M, et al. Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer. Asian Pac J Cancer Prev, 2011, 12(8): 1973-1977.
|
| 36. |
Chen D, Zhang J, Minnerly J, et al. daf-31 encodes the catalytic subunit of N alpha-acetyltransferase that regulates Caenorhabditis elegans development, metabolism and adult lifespan. PLoS Genet, 2014, 10(10): e1004699.
|
| 37. |
Meza-Carmen V, Pacheco-Rodriguez G, Kang GS, et al. Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1. Proc Natl Acad Sci U S A, 2011, 108(26): 10454-10459.
|